Tenovi has launched a new FDA-cleared cellular-connected blood pressure monitor designed to improve preventive care for high-risk patients, particularly in maternal health and stroke prevention. The device features irregular heartbeat detection and is compatible with Tenovi’s large-size cuff, making it suitable for a wide range of adult patients—including those with diabetes, pregnancy-related hypertension, or preeclampsia. As part of Tenovi’s remote patient monitoring (RPM) platform, this innovation allows for real-time data transmission without the need for apps, Wi-Fi, or syncing, ensuring seamless integration into both home and clinical environments.

The device connects through Tenovi’s proprietary Cellular Gateway, which supports over 40 FDA-cleared Bluetooth devices for continuous monitoring of vital signs, medication adherence, and physical activity. Its user-friendly design features a simple red-green LED system: a red light prompts the patient to take a reading, and a green light confirms the transmission of the data to their care team. This plug-and-play RPM system ensures better compliance and enhances early detection of rising blood pressure or irregularities, enabling clinicians to intervene before complications such as stroke occur.